Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Lakshmi R, Gokanapudy"'
Autor:
Sarah R. de Loizaga, Lindsay Arthur, Bhawna Arya, Brian Beckman, Wubishet Belay, Cole Brokamp, Nak Hyun Choi, Sean Connolly, Soham Dasgupta, Tavenner Dibert, Marylou M. Dryer, Lakshmi R. Gokanapudy Hahn, Elizabeth Anne Greene, Daphney Kernizan, Omar Khalid, Jennifer Klein, Ryan Kobayashi, Subhrajit Lahiri, Raymond P. Lorenzoni, Andrea Otero Luna, Jennifer Marshall, Theodore Millette, Lily Moore, Babu Muhamed, Meghna Murali, Kinjal Parikh, Amy Sanyahumbi, Divya Shakti, Elizabeth Stein, Sanket Shah, Hannah Wilkins, McAllister Windom, Scott Wirth, Meghan Zimmerman, Andrew F. Beck, Nicholas Ollberding, Craig Sable, Andrea Beaton
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 10, Iss 16 (2021)
Background Recent evaluation of rheumatic heart disease (RHD) mortality demonstrates disproportionate disease burden within the United States. However, there are few contemporary data on US children living with acute rheumatic fever (ARF) and RHD. Me
Externí odkaz:
https://doaj.org/article/c4ed5e46d7a34869a9894a4c04deb529
Autor:
Elizabeth Stein, Raymond P. Lorenzoni, Meghan Zimmerman, Andrew F. Beck, Babu Muhamed, Kinjal Parikh, Sean Connolly, Soham Dasgupta, Nicholas J Ollberding, Nak Hyun Choi, Scott Wirth, Elizabeth Anne Greene, Marylou M Dryer, Daphney Kernizan, Jennifer A. Marshall, Jennifer Klein, Hannah Wilkins, Sarah R de Loizaga, Ryan Kobayashi, Divya Shakti, Craig Sable, Andrea Otero Luna, Cole Brokamp, Wubishet Belay, Bhawna Arya, Lily Moore, Omar Khalid, Lindsay Arthur, Amy E. Sanyahumbi, Tavenner Dibert, McAllister Windom, Andrea Beaton, Meghna Murali, Brian Beckman, Theodore Millette, Lakshmi R Gokanapudy Hahn, Sanket Shah, Subhrajit Lahiri
Publikováno v:
Journal of the American Heart Association. 10
Background Recent evaluation of rheumatic heart disease (RHD) mortality demonstrates disproportionate disease burden within the United States. However, there are few contemporary data on US children living with acute rheumatic fever (ARF) and RHD. Me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3c4dad1bf27258ca734263127e15ee1e
https://doi.org/10.1161/jaha.120.020992
https://doi.org/10.1161/jaha.120.020992
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Kenneth E. Remy, Ibrahim Abdullah, Lakshmi R. Gokanapudy, Robert E. Michler, Michael Ruppe, Joseph D. Tobias, Eneida V. Melgar Humala, William S. Schechter, Sathappan Karuppiah
Publikováno v:
Cardiology Research
Total anomalous pulmonary venous return (TAPVR) is a rare congenital cardiac defect, accounting for 1.5-3% of cases of congenital heart disease. With prenatal ultrasonography, the majority of these patients are diagnosed in utero with definitive surg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::efb8fa0899af20b241655de82743f4d6
http://europepmc.org/articles/PMC5819631
http://europepmc.org/articles/PMC5819631
Autor:
Sudipta Mohanty, Patrick Looser, Bibhu D Mohanty, Martin E. Goldman, Valentin Fuster, Jonathan L. Halperin, Rishi Handa, Sharon S Choi, Lakshmi R Gokanapudy
Publikováno v:
Vascular Medicine. 19:190-204
Increasing use of the new oral anticoagulants (NOACs) – dabigatran, rivaroxaban, and apixaban – has prompted considerable discussion in the medical community even as warfarin remains the mainstay of therapy. This article raises 10 controversial i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7c93588a0ceddae309ae59eadd85f7f4
https://doi.org/10.1177/1358863x14532869
https://doi.org/10.1177/1358863x14532869
Autor:
Bibhu D, Mohanty, Patrick M, Looser, Lakshmi R, Gokanapudy, Rishi, Handa, Sudipta, Mohanty, Sharon S, Choi, Martin E, Goldman, Valentin, Fuster, Jonathan L, Halperin
Publikováno v:
Vascular medicine (London, England). 19(3)
Increasing use of the new oral anticoagulants (NOACs) - dabigatran, rivaroxaban, and apixaban - has prompted considerable discussion in the medical community even as warfarin remains the mainstay of therapy. This article raises 10 controversial issue
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ee1924fc601e3f91b67aa58adc7b5376
https://pubmed.ncbi.nlm.nih.gov/24879715
https://pubmed.ncbi.nlm.nih.gov/24879715